Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Regenerative Medicine Market is estimated to register a CAGR of 27.2% by 2031…
Download a detailed overview: Download a detailed overview: https://www.skyquestt.com/sample-request/regenerative-medicine-market Regenerative Medicine Market Overview: Segments covered in Regenerative Medicine Market are as follows: Request Free Customization of this report: https://www.skyquestt.com/speak-with-analyst/regenerative-medicine-market Cell Therapy: Pioneering the Future of Healing The market leader in regenerative medicine, cell therapy, with a...
PR Newswire
01/08/2024
Structural Steel Tube Market to Reach $167.5 billion, Globally, by 2033 at 4.8%…
Prime determinants of structural steel tube market growth Prime determinants of structural steel tube market growth The global structural steel tube market is experiencing growth due to infrastructure development and technological advancements. However, fluctuations in raw material prices and environmental regulations hinder the market growth. Moreover, rise in demand for steel tubes from emerging markets, and global awareness towards sustainability provide opportunities for expanding the...
PR Newswire
01/08/2024
Non-Insulin Therapies for Diabetes Market to Reach USD 58.6 Billion by 2034…
Non-insulin therapies are generally preferred by healthcare personnel in patients suffering from type 2 diabetes, in which body either fails to produce enough insulin or is incapable of using the insulin that it produces. Certain non-insulin agents facilitate increase of insulin release from the pancreatic cells (sulfonylureas), whereas some of them increase glucose uptake peripherally and reduce hepatic glucose output (Biguanides). Non-insulin therapies are generally preferred by healthcare...
PR Newswire
01/08/2024
Healthcare Predictive Analytics Market to Reach $128.2 Billion, Globally, by…
Request Sample of the Report on Healthcare Predictive Analytics Market Forecast 2033 - https://www.alliedmarketresearch.com/request-sample/A292452 Request Sample of the Report on Healthcare Predictive Analytics Market Forecast 2033 -https://www.alliedmarketresearch.com/request-sample/A292452 Prime determinants of growth The global healthcare predictive analytics market is experiencing growth due to several factors such as an increase in adoption of electronic health records...
PR Newswire
01/08/2024
Pain Management Drugs Market to Reach $109.6 Billion, Globally, by 2033 at 4.2%…
Request Sample of the Report on Pain Management Drugs Market Forecast 2033 - https://www.alliedmarketresearch.com/request-sample/404 Request Sample of the Report on Pain Management Drugs Market Forecast 2033 -https://www.alliedmarketresearch.com/request-sample/404 Prime determinants of growth Rise in incidences of chronic diseases, favorable regulatory scenario, and increase in geriatric population are the major factors that drive the growth of the pain management drugs market...
PR Newswire
01/08/2024
Non-Hodgkin's Lymphoma Therapeutics Market to Reach USD 18.6 Billion by 2034…
The use of immune checkpoint inhibitors and CAR-T cell therapies is becoming more prevalent, offering new hope for NHL patients. Combining different therapeutic approaches (e.g., chemotherapy with targeted therapy) is gaining traction to improve efficacy and reduce resistance. Advances in biomarker identification are enhancing the ability to diagnose NHL early and tailor treatments to individual patients. Increased access to healthcare in emerging markets is expanding the availability of NHL…
PR Newswire
01/08/2024
Swiss Health Tech Startup Aktiia Names Industry Veteran Rags Gupta as new CEO as…
"Aktiia's mission to reduce the impact of blood pressure on global health is deeply personal. Add to this the novel technology that's already achieved product market fit and improved patient outcomes, the unique dataset, and the talented, dedicated team, and it makes for a once-in-career opportunity. I'm thrilled to join at such an inflection point in the business," said Rags Gupta. "It's time to scale." "Aktiia's mission to reduce the impact of blood pressure on global…
PR Newswire
01/08/2024
Cumulus Neuroscience Presents Data at AAIC 2024 Annual Meeting and Technology…
"While clinic-based biomarkers are effective in tracking disease progression and therapeutic efficacy in clinical research, they are not scalable and lack objectivity," said Brian Murphy, PhD, Founder and Chief Scientific Officer of Cumulus. "Our CNS-101 study was executed in collaboration with the Cumulus Pharma Advisory Group which is comprised of leading scientists from ten top pharma companies. It has validated that patients living with Alzheimer's dementia are capable and…
PR Newswire
01/08/2024
FLEXSYS TO INCREASE PRICES FOR INSOLUBLE SULFUR, 6PPD AND 4-ADPA PRODUCTS…
Furthermore, Flexsys is making significant investments in the innovation of a Next Generation Antidegradant as a replacement for 6PPD to respond to customers' requests for a more sustainable Antidegradant for tires of the future. Furthermore, Flexsys is making significant investments in the innovation of a Next Generation Antidegradant as a replacement for 6PPD to respond to customers' requests for a more sustainable Antidegradant for tires of the future. Collectively, these actions will...
PR Newswire
01/08/2024
ENGWE Launches L20 Boost ebike: Empowering Short Trips with the "BOOST" Button
With the brand slogan "Explore a new way," ENGWE aims to redefine short-distance travel, making it more accessible and enjoyable for urban commuters and recreational riders alike. so the ENGWE L20 Boost fat tire ebike is crafted to elevate every journey with seamless hill-climbing capabilities and a smooth, responsive riding experience. The upgraded "Boost" function effortlessly tackles inclines up to 17.8% with the touch of a button, meeting all your daily commuting and…
PR Newswire
01/08/2024
Leqembi revenue more than doubled - totaled JPY 6.3 billion in the second…
BioArctic's report for the second quarter 2024 will be published on August 29 at 08.00 a.m. CET. BioArctic's report for the second quarter 2024 will be published onAugust 29at08.00 a.m. CET. This information is information that BioArctic AB (publ) is obliged to disclose pursuant to the EU Market Abuse Regulation. The information was released for public disclosure, through the agency of the contact persons below, onAugust 1, 2024, at12.45 p.m. CET. For further...
PR Newswire
01/08/2024
uniQure Announces Second Quarter 2024 Financial Results and Provides Company…
~ Announced RMAT designation for AMT-130 in Huntington's disease and positive interim Phase I/II data demonstrating the slowing of disease progression and reductions in a key biomarker of neurodegeneration; Meeting with FDA expected in the second half of 2024 to discuss potential for expedited clinical development ~ ~ Initiated patient screening for three additional Phase I/II studies in mesial temporal lobe epilepsy, SOD1 ALS, and Fabry disease ~~ Today, announced an organizational...
Nasdaq GlobeNewswire
01/08/2024
Aurora Cannabis and Vectura Fertin Pharma, Inc. announce commercial…
Aurora Cannabis and Vectura Fertin Pharma, Inc. announce commercial collaborationCollaboration will initially see launch of a new CBD lozenge from Cogent International, a Vectura Fertin Pharma subsidiary, on Aurora's Canadian medical cannabis patient platformFollowing successful launch of CBD lozenge, the collaboration will explore the potential to launch Vectura Fertin Pharma's future medical cannabis portfolio in CanadaEdmonton, AB, and Stamford, CT – August 1, 2024- Aurora...
Nasdaq GlobeNewswire
01/08/2024
Compass Pathways announces second quarter 2024 financial results and business…
Top-line COMP005 data for COMP360 phase 3 pivotal program in treatment-resistant depression expected in fourth quarter 2024Gino Santini to join Board of Directors as ChairmanLori Englebert named new Chief Commercial OfficerCash position of $228.6 millionConference call August 1 at 8:00 am ET (1:00 pm UK) LONDON and NEW YORK, Aug.01, 2024(GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating access...
Nasdaq GlobeNewswire
01/08/2024
UV-Absorbing Chemicals for Cosmetics Market to Reach US$ 1.1 Billion by 2034…
UV-absorbing substances shield the skin from UV rays by reflecting or absorbing them. They are used in a variety of cosmetic goods, including over-the-counter sunscreens and other items for personal hygiene. UV-absorbing substances shield the skin from UV rays by reflecting or absorbing them. They are used in a variety of cosmetic goods, including over-the-counter sunscreens and other items for personal hygiene. Sunscreen products are mainly utilized in situations where complete protection...
PR Newswire
01/08/2024
Nucleic Acid Therapeutics Market to Reach USD 22.1 Billion by 2034, Advances in…
Advances in genetic research and biotechnology are propelling the nucleic acid therapeutics market value. These medicines, which include antisense oligonucleotides (ASOs), RNA interference (RNAi), and RNA aptamers, provide targeted treatments for a range of genetic abnormalities, infectious diseases, and malignancies. Advances in genetic research and biotechnology are propelling the nucleic acid therapeutics market value. These medicines, which include antisense oligonucleotides (ASOs), RNA...
PR Newswire
01/08/2024
Infusion Pump Market is expected to reach USD 209.8 Million by 2034, growing at…
The aging population is expected to drive the demand for infusion pumps over the forecast period. As people age, they are more likely to require medical treatment, which can include the use of infusion pumps. In addition, the elderly population is more likely to suffer from chronic diseases, further driving the demand for these devices. The aging population is expected to drive the demand for infusion pumps over the forecast period. As people age, they are more likely to require medical...
PR Newswire
01/08/2024
President of Ghana Marks Successful LiuGong Equipment Delivery
"Ghana is at a critical stage of rapid development. To achieve economic takeoff, it is essential to first address the key issue of infrastructure construction. The government's procurement of a thousand units of LiuGong equipment has profound significance for improving transportation conditions in our rural areas and enhancing local livelihoods." " Ghanais at a critical stage of rapid development. To achieve economic takeoff, it is essential to first address the key issue of…
PR Newswire
01/08/2024
VERSACE HOME DRESSES RGZ DEVELOPERS LUXULY VILLAS WITH HAUTE COUTURE
About Versace Home About Versace Home Versace Home extends Versace's fashion design vision to a way of living. The same energy, refinement, and signature modernity of Versace fashion collections are reflected through a complete home and lifestyle design collection that includes furniture, textiles, porcelain, glassware, interior décor, and more. True icons of Versace such as the Medusa, Greca, and Barocco, are as immediately recognizable and powerful across the back of an armchair,...
PR Newswire
01/08/2024
Immunovia completes development of its pancreatic cancer detection test after…
A sensitivity of 85% means the new test is capable of detecting pancreatic cancer in approximately 6 out of every 7 people with early-stage disease. Specificity of 98% means this new test should return a false positive result just once for every 50 people tested who do not have pancreatic cancer. Test performance was refined by leveraging additional samples with more complete and detailed clinical information and through more sophisticated statistical modeling. Test performance was independently…
PR Newswire
01/08/2024
Premium Trendy Products, Direct Sourcing, Efficient Matchmaking - Don't Miss the…
The fair will highlight the latest trends and high-quality products in the kids industry across eight major categories, including prams & accessories, children's car seats, ride-on products, baby furniture & home items, baby feeding & nursery products, health care and bathing products, home safety products, and infant toys. 8,000+ international buyers from 130+ countries and regions are expected to attend. The fair will highlight the latest trends and high-quality products in…
PR Newswire
01/08/2024
WuXi Biologics' Four Manufacturing Facilities and Biosafety Testing Center…
WuXi Biologics has a proven track record of strict quality compliance. Since 2017, the company has completed and passed 35 global regulatory agency inspections, more than 1,250 GMP quality audits by global clients, and more than 145 audits by EU Qualified Persons. Currently, WuXi Biologics has 15 GMP-certified drug substance and drug product facilities in its global network. WuXi Biologics has a proven track record of strict quality compliance. Since 2017, the company has completed and passed...
PR Newswire
01/08/2024
Novo Holdings Invests in UK-Listed Oxford Nanopore Technologies
Dr Daniel Mahony, Senior Partner, Growth Investments, Novo Holdings, said: "Oxford Nanopore has made impressive ongoing progress to advance its technology platform and gain commercial traction. This investment underscores our belief in Oxford Nanopore's platform and its expanding opportunity in biopharmaceuticals, where rapid sequencing, richer data and a streamlined platform can support discovery and delivery of new drug therapies. We are confident in Oxford Nanopore's long-term value…
PR Newswire
01/08/2024
CMR Surgical embarks on world-first paediatric clinical trial using Versius
CMR Surgical embarks on world-first paediatric clinical trial using VersiusCMR Surgical has commenced the world's first multicentre prospective clinical trial on the use of Versius in paediatric surgery Led by Mr Ewan Brownlee, Consultant Paediatric Urologist at the Southampton Children's Hospital, part of the University Hospital Southampton NHS Foundation Trust, the prospective clinical study will assess the safety and efficacy of Versius, for use in urological procedures in...
Nasdaq GlobeNewswire
01/08/2024
Altri Comunicati
